Dean Berhaupt has become the first patient to receive CAR T-cell therapy in Albany, marking a significant milestone for ...

Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

A new review has found a lack of convincing evidence stem cell injections are helpful for knee osteoarthritis. But there are ...

Alcon said that its majority stake means that Aurion will have "broader R&D, regulatory, medical ophthalmic, and commercial ...

"We were able to get to yields where we could ask questions about whether these cells can be viable candidates for the cell replacement ... these cells as a therapy, the researchers showed that ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Variant, a company dedicated to developing innovative treatments for orphan inherited eye diseases, and the Rare Ocular Diseases Center at the University ofCampania Luigi Vanvitelli ...

Allogeneic therapy can be a viable and promising option for treating ... allow for sophisticated gene editing (including gene insertion, deletion, repair and replacement in T cells) to address such ...

Cell replacement for Parkinson’s disease replaces the dopamine ... at Harvard Medical School and Mass General Brigham, has pioneered work in cell therapy for Parkinson’s disease over the past 30 years ...

Scientists at the Allen Institute have made a major breakthrough in research for people living with Dravet Syndrome, which is ...